NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹126 Cr | ₹104 Cr | ₹108 Cr | ₹83 Cr | ₹38 Cr |
What is the latest Net Current Assets ratio of NGL FINECHEM ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹126 Cr |
Mar2023 | ₹104 Cr |
Mar2022 | ₹108 Cr |
Mar2021 | ₹83 Cr |
Mar2020 | ₹38 Cr |
How is Net Current Assets of NGL FINECHEM Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹126 Cr | 20.81 | |
Mar2023 | ₹104 Cr | -3.22 | |
Mar2022 | ₹108 Cr | 30.30 | |
Mar2021 | ₹83 Cr | 118.82 | |
Mar2020 | ₹38 Cr | - |
Compare Net Current Assets of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,110.0 Cr | -2% | -11% | -8.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -2% |
-11% |
-8.4% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses